EuroValve
October 24-25 2014
Roma Eventi Fontana di Trevi
Rome, Italy
www.eurovalvecongress.com
Course directors:
Patrizio Lancellotti, Liege, Belgium
Khalil Fattouch, Palermo, Italy
Gilbert Habib, Marseille, France
José Luis Zamorano, Madrid, Spain
EuroValve
Synoptic
Edito
Welcome to EuroValve 2014!
www.eurovalvecongress.com
FRIDAY OCTOBER 24
It is a great pleasure to welcome you for this second edition in the beautiful city of Rome, which
offers something for everyone: whether you are a culture or art passionate, an Italian cuisine
lover, a fashion addict, The Romantic City is sure to please you.
As you may know, this year we will favor more interactivity and discussions, especially thanks to
several symposia and controversies.
Again, over 2 days, we will present an extensive program dedicated to valvular heart disease,
focusing on genetics, surgery, epidemiology, transcatheter valve replacement, echocardiography,
new imaging.
New this year, we are hosting an ePoster competition with outstanding scientific works from
selected abstracts received, that you will have the opportunity to view on the interactive screens
onsite on the exhibition hall.
Take your time to visit the exhibition and discover the Industry news as it is only thanks to their
precious help that we could achieve our ambitious program and do not miss Abbott symposium
on Friday and Sorin symposium on Saturday in the plenary room.
We are very pleased to have you during two convivial days of fruitful teaching in the eternal city.
Enjoy the congress!
The EuroValve Directors
Patrizo Lancellotti, Khalil Fattouch, Gilbert Habib and José Luis Zamorano
Scientific Program Committee
Ottavio Alfieri, Milan, Italy
Bernard Iung, Paris, France
Philippe Kolh, Liege, Belgium
Giovanni La Canna, Milan, Italy
Gerald Maurer, Vienna, Austria
Luc Piérard, Liege, Belgium
Bernard Prendergast, Oxford, United Kingdom
Raphael Rosenhek, Vienna, Austria
Giuseppe Speziale, Bari, Italy
Christophe Tribouilloy, Amiens, France
08:30 Opening ceremony
Patrizio Lancellotti, Khalil Fattouch,
Gilbert Habib, José Luis Zamorano
SATURDAY OCTOBER 25
08:30 Symposium:
the mystery of tricuspid valve
Ottavio Alfieri, Philippe Unger
08:45 Symposium:
measuring the risk in valve patients
Bernard Prendergast, Luc Piérard
(Joint with ESC WG Valve Disease)
09:30 Keynote lecture J. Bergler-Klein, B. Cosyns
09:45 Keynote lecture J. L. Zamorano, G. Habib 09:45 Coffee break in the exhibition hall
10:05 Coffee break in the exhibition hall
10:15 Symposium:
rhythm and mechanical activation
10:30 Symposium:
controls in VHD
challenges for the clinical cardiologists.
Jose Luis Zamorano
Is Echo-Imaging helpful?
Gerald Maurer, Victoria Delgado
(Joint with the EACVI)
11:30
Surgical talk on demand: focus on
minimally invasive approach G. Speziale
11:30
Symposium
Patients Live Innovation
12:30
Lunch break in the exhibition hall
12:00 Symposium
Your future with MitraClip
José Luis Zamorano, Raphael Rosenhek
13:00 Lunch break in the exhibition hall
13:30 Clinical session:
challenging clinical situation
14:00 Symposium:
diagnostic and treatment of patients
with aortic regurgitation
Gerald Maurer, Khalil Fattouch
Paolo Colonna, Arturo Evangelista
15:00 Clinical session:
challenging the guidelines
Faculty
Jutta Bergler-Klein, Vienna, Austria
Paolo Colonna, Rome, Italy
Bernard Cosyns, Braine-L’Alleud, Belgium
Victoria Delgado, Leiden, The Netherlands
Mauro Del Giglio, Cotignola, Italy
Alessandro Della Corte, Naples, Italy
Erwan Donal, Rennes, France
Raluca Dulgheru, Brussels, Belgium
Giovanni Esposito, Naples, Italy
Arturo Evangelista, Barcelona, Spain
Maurizio Galderisi, Naples, Italy
Alexandra Gonçalves, Boston, USA
October 24-25 2014, Rome, Italy
Julien Magne, Limoges, France
Thomas Modine, Lille, France
Jean-Luc Monin, Créteil, France
Giuseppe Nasso
Cécile Oury, Liege, Belgium
Agnes Pasquet, Brussels, Belgium
Philippe Pibarot, Quebec, Canada
Prakash Punjabi, London, United-Kingdom
Martin J. Swaans, Nieuwegein, The Netherlands
Pilar Tornos, Barcelonna, Spain
Philippe Unger, Brussels, Belgium
Eucomed Code of Ethical Business Practice: COMPLIANT
15:30 Keynote lecture
Philippe Kolh, Patrizio Lancellotti
Erwan Donal, Giovanni La Canna
16:00 Coffee break in the exhibition hall
16:30 Controversies in VHD
Bernard Iung, Pilar Tornos
16:30 Closing remarks / ePosters awards
ceremony
Patrizio Lancellotti, Khalil Fattouch,
Gilbert Habib, José Luis Zamorano
17:30 Controversy:
when to operate in infective
endocarditis?
Ottavio Alfieri
18:30 End of the sessions
www.eurovalvecongress.com
Friday October 24, 2014
08:30
Opening ceremony
Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano
08:45
Symposium: measuring the risk in valve patients
08:45
08:58
09:11
09:24
Bernard Prendergast, Luc Piérard (Joined with ESC WG Valve Disease)
• EuroScore II and STS score: are they similar? Julien Magne
• Lessons learnt from the TAVI story? Bernard Iung
• How to evaluate the risk in elderly subjects? Raphael Rosenhek
• An illustrative case, Patrizio Lancellotti
• Round table discussion
09:45
Keynote lecture
09:45
José Luis Zamorano, Gilbert Habib
• Controversies in tricuspid regurgitation: risk marker? Patrizio Lancellotti
10:05
Coffee break in the exhibition hall
10:30Symposium: challenges for the clinical cardiologists. Is Echo-Imaging helpful?
Gerald Maurer, Victoria Delgado (Joined with the EACVI)
10:30
10:45
11:00
Focus on aortic valve
Clinical case: a 70-years old attorney with severe aortic stenosis, impaired LV systolic function and mitral regurgitation
• Severe or not? Philippe Pibarot
• When to operate? Christophe Tribouilloy
• Should we repair/replace the mitral valve? Maurizio Galderisi
11:30
Surgical talk on demand: focus on minimally invasive approach
11:30
11:40
Giuseppe Speziale, Martin J. Swaans
• Does minimally invasive mitral valve repair compromise the results? Khalil Fattouch
•Mininvasive mitral valve repair live cases (Anthea Hospital, Bari, Italy)
Surgeon: Giuseppe Nasso
•Does minimally invasive aortic replacement reduce risk of surgery?
Mauro del Giglio
11:50
12:00
Symposium
Your future with MitraClip, José Luis Zamorano, Raphael Rosenhek
MDT panel: Dabit Arzamendi, Victoria Delgado, Ottavio Alfieri, Raphael Rosenhek
12:00
• Introduction, Raphael Rosenhek
12:03
• Mitral Regurgitation: how big is the problem? José Luis Zamorano
12:15
• Who is the right MitraClip patient? Victoria Delgado
12:27
• When to refer for MitraClip? Ottavio Alfieri
12:39
• Why and how to start with MitraClip? Dabit Arzamendi
• MDT Q&A
12:52
• Take home, Raphael Rosenhek
13:00
Lunch break in the exhibition hall
14:00
Symposium: diagnostic and treatment of patients with aortic regurgitation
14:00
14:18
14:36
14:54
15:12
Gilbert Habib, Patrizio Lancellotti
• Pathophysiology of aortic regurgitation, Pilar Tornos
• What are the best diagnostic tools to quantify aortic regurgitation? Agnes Pasquet
•How should patients with AR be followed-up and when is the best time to
operate? Raphael Rosenhek
• State of the art aortic valve/root surgery for AR, Alessandro Della Corte
• Is there a place for transcatheter valve implantation? Giovanni Esposito
15:30
Keynote lecture
15:30
Erwan Donal, Giovanni La Canna
TAVI: worldwide experience and new trends, Thomas Modine
16:00
Coffee break in the exhibition hall
16:30
Controversies in VHD
Bernard Iung, Pilar Tornos
16:30
•Paravalvular regurgitation, even mild, is a risk factor for mortality following TAVI, Jean-Luc Monin
17:00
• Mild paravalvular regurgitation is not an independent predictor of mortality following
TAVI, Philippe Pibarot
17:30
Controversy: when to operate in infective endocarditis?
Ottavio Alfieri
17:30
18:00
• Earlier is the must? Gilbert Habib
• Always later? Bernard Prendergast
18:30
End of the sessions
Saturday October 25, 2014
ePosters competition
08:30
Symposium: the mystery of tricuspid valve
08:30
08:45
09:00
09:15
Ottavio Alfieri, Philippe Unger
• Functional anatomy of the tricuspid valve and right ventricle, Khalil Fattouch
• Imaging assessment, Jose Luis Zamorano
• When to operate? Luc Piérard
• Surgical techniques and outcomes, Prakash Pubjabi
• Round table discussion
• Implantation of an Edwards Intuity rapid deployement aortic valve: one year single center
Experience, Gian Luca Martinelli, Maurizio Braccio, Attilio Cotroneo, Rossella Alemanni,
Rosamaria Montesanti, Mauro Cassese
09:30
Keynote lecture
09:30
Jutta Bergler-Klein, Bernard Cosyns
• Emerging biomarkers in VHD, Cécile Oury
09:45
Coffee break in the exhibition hall
10:15
Symposium: rhythm and mechanical activation controls in VHD
10:15
10:33
10:51
11:09
Jose Luis Zamorano
• AF in VHD: a turning point in the natural history, Erwan Donal
• Surgical ablation of AF in VHD, Philippe Kolh
• MitraClip and CRT in mitral regurgitation: a good marriage? Victoria Delgado
•Dyssynchrony in aortic stenosis and no flow reserve: a reality? Raluca Dulgheru
11:30Symposium
Patients Live Innovation
Sorin solutions for aortic and Mitral procedures
Borut Gersak, Patrizio Lancellotti
• Aortic Valve in Valve Implantation in the Mitroflow Bioprosthetic Valve: a review of
current literature, Brian Bethea
• Native-like performance: the Solo Smart experience, Herko Grubitzsch
• Improving patient outcome in AVR: the Perceval experience, Sergio Canovas
• Outcomes after restrictive annuloplasty in IMR: clinical impact of different rings,
Khalil Fattouch
12:30
Lunch break in the exhibition hall
13:30
Clinical session: challenging clinical situation
13:30
13:52
14:14
14:36
Gerald Maurer, Khalil Fattouch
• A patient with multiple valve disease, Philippe Unger
• A young patient with aortic valve endocarditis, Gilbert Habib
• A patient with angina and moderate aortic stenosis, Alexandra Gonçalves
• A patient with VHD and desire for pregnancy, Bernard Iung
15:00
Clinical session: challenging the guidelines
15:00
15:22
15:44
16:06
Philippe Kolh, Patrizio Lancellotti
• Mitral regurgitation, Giovanni La Canna
• Aortic stenosis, Julien Magne
• Aortic regurgitation, Victoria Delgado
• Marfan disease, Arturo Evangelista
16:30
Closing remarks / ePosters awards ceremony
Patrizio Lancellotti, Khalil Fattouch, Gilbert Habib, José Luis Zamorano
•O
utcome of patients with low-flow aortic stenosis with preserved ejection fraction. Are there
differences according to the echocardiographic parameters?
Nuria Vallejo Camazon, Gladys Junca, Elena Ferrer, Francisco Gual, Jorge Lopez Ayerbe,
Albert Teis, Antoni Bayes Genis
•E
ndocarditis in octogenarians. Less surgery and higher mortality in our area nowadays?
Gladys Junca, Nuria Vallejo Camazon, Elena Ferrer, Jorge Lopez Ayerbe, Albert Teis,
Raquel Pla, Carlos Diez, Francisco Gual, Antoni Bayes Genis
• Impact of patient prosthesis mismatch on left ventricular filling pressure increase after
transcatheter aortic valve implantation, Galderisi Maurizio, Marco Fabio Costantino,
Ciro Santoro, Giandomenico Tarsia, Pasquale Innelli, Ernesta Dores, Antonella Matera,
Giovanni Esposito, Giovanni de Simone, Bruno Trimarco
•C
linical significance of serial BNP changes in asymptomatic patients with aortic stenosis,
Christine Henri, Raluca Dulgheru, Julien Magne, Luis Caballero, Saloua Laaraibi,
Seisyou Kou, Damien Voilliot, Laurent Davin, Luc Pierard, Patrizio Lancellotti
•R
elationship between left atrial deformation and B-type natriuretic peptide activation in
asymptomatic aortic stenosis, Christine Henri, Raluca Dulgheru, Julien Magne, Seisyou Kou,
Laurent Davin, Alain Nchimi, Cecile Oury, Luc Pierard, Patrizio Lancellotti
•L
eft ventricular longitudinal deformation and B-type natriuretic peptide activation and
changes in asymptomatic aortic stenosis, Christine Henri, Raluca Dulgheru, Julien Magne,
Seisyou Kou, Laurent Davin, Alain Nchimi, Cecile Oury, Luc Pierard, Patrizio Lancellotti
•D
ouble orifice mitral valve, Amina Elfhal, Ilham Bensahi, Maria Melissoupoulou,
Elena Dulgheru, Luc Pierard, Patrizio Lancellotti
•A
scending aortic elastic properties and LV longitudinal function in isolated bicuspid aortic
valve by speckle tracking echocardiography, Fabio D’Aiello, Danila Avitabile,
Giovanni Di Salvo, Ciro Bancone, Marianna Buonocore, Marco Montibello,
Maria Giovanna Russo, Alessandro Della Corte
•S
creening for valvular heart disease: anxiety and attitudes in the oxVALVE population cohort
study, Joanna d’Arcy, Sean Coffey, Margaret Loudon, Louise Locock, Andrew Farmer,
Bernard Prendergast
•M
inimally invasive approach for aortic surgery in octogenarians, Luigi Specchia, Salvatore
Nicolardi, Federica Mangia, Mattia Scognamiglio, Olivera Rasovic, Salvatore Foggetti,
Salvatore Lentini, Renato Gregorini, Giuseppe Di Eusanio
•Q
uadricuspid aortic valve associated with a genesis of circumflex coronary: a rare
congenital cardiac entity, Ilham Bensahi, Amina Elfhal, Raluca Dulgheru, Christine Henri,
Luc Pierard, Patrizio Lancellotti
•L
eft ventricular mass regression early after sutureless implantation of the ATS 3F enable
aortic valve bioprosthesis, Luca Salvatore De Santo, Stefano de Notaris, Emilio Mango,
Leonardo Savarese, Francesco Iorio, Mario Miele, Flora Numis, Donato Catapano,
Paola Tesorio, Sergio Maria Caparrotti
•S
utureless 3F enable valve in valve implantation for tricuspid bioprosthesis degeneration,
Stefano de Notaris, Luca Salvatore De Santo, Emilio Mango, Leonardo Savarese,
Francesco Iorio, Mario Miele, Flora Numis, Donato Catapano, Paola Tesorio,
Sergio Maria Caparrotti
ePosters competition
•P
ercutaneous valve in valve treatment of degenerate tricuspid bio prosthesis by
transfemoral route, Fausto Castriota, Flavio Ribichini, Mauro Del Giglio,
Gabriele Pesarini, Corrado Vassanelli, Alberto Cremonesi
•T
he impact of ethnicity on the prevalence and length of hospital stay in patients
with aortic valve stenosis, Clare Thakker, Nicholas D Gollop, Paul Carter,
Hardeep Uppal, Suresh Chandran, Rahul Potluri
•R
isk stratification in severe aortic stenosis: the importance of ventriculo-arterial
interplay, Elena Galli, Emmanuel Oger, Yvan Guirette, Vincent Auffret,
Philippe Mabo, Erwan Donal
•C
linical outcomes of aortic valve repair in asymptomatic patients with chronic
severe aortic valve regurgitation, Egle Corrado, Benedetta La Fata,
Emanuela Clara Bertolino, Patrizia Carità, Giuseppa Caccamo, Claudia Visconti,
Sebastiano Castrovinci, Giacomo Murana, Antonio Rubino, Carmelo Mignosa,
Marco Moscarelli, Prakash Punjabi, Khalil Fattouch
•T
en years follow-up of Bicuspid Aortic Valve (BAV) Repair according to
morphology, functional classification and surgical tecniques, Khalil Fattouch,
Giacomo Murana, Sebastiano Castrovinci, Patrizia Carità,
Emanuela Clara Bertolino, Giuseppa Caccamo, Egle Corrado, Pietro Dioguardi,
Giuseppe Nasso, Giuseppe Speziale, Marco Moscarelli, Prakash Punjabi
•S
hort-term clinical outcomes among patients undergoing transcatheter aortic
valve implantation (TAVI) in a single centre, Armando Pucciarelli, Tullio Tesorio,
Linda Cota, Angelo Cioppa, Gregory Popusoy, Eugenio Stabile, Luigi Salemme,
Paolo Rubino
•L
eft atrial systolic function impairment and prognosis in severe aortic stenosis,
Elena Galli, Yvan Guirette, Vincent Auffret, Philippe Mabo, Erwan Donal
•L
eft ventricular global longitudinal strain predicts post-operative left ventricular
dysfunction in patients with primary mitral regurgitation, Elena Galli,
Emmanuel Oger, Mayliss Levery, Philippe Mabo, Erwan Donal
•A
ortic regurgitation after transcatheter valve implantation: subvalvular calcification
as a predictor of paraprosthetic regurgitation, Angelo Squeri, Stefano Censi,
Marco Baldelli, Chiara Grattoni, Fausto Castriota, Stefano Bosi, Alberto Cremonesi
•P
revalence and determinants of right ventricular dysfunction in severe aortic
stenosis, Elena Galli, Yvan Guirette, Vincent Auffret, Philippe Mabo, Erwan Donal
•C
an left ventricular afterload influence rv function in aortic stenosis? Elena Galli,
Yvan Guirette, Philippe Mabp, Erwan Donal
•V
entriculo-arterial impedance differently impact 2D strain parameters in patients
with aortic stenosis, Elena Galli, Yvan Guirette, Philippe Mabo, Erwan Donal
•T
he impact of ethnicity on the prevalence and length of hospital stay in patients
with mitral regurgitation, Syed Kazim Ali Shan, Joshim Khan, Fatemah Ziaei,
Raj Bhayani, Savana Shakir, Hardeep Uppal, Suresh Chandran, Rahul Potluri
•D
oes the preoperative left atrium size influence the outcome of surgical
radiofrequency ablation in associated atrial fibrillation? Gheorghe Cerin, Bogdan
Adrian Popa, Silvia Simonini, Levan Karazanishvili, Diana Benea, Anamaria Popa,
Marco Diena, Romano Angelo
•E
arly and mid-term outcomes after aortic valve replacement with a sutureless prosthesis:
single center experience, Carmelo Mignosa, Salvatore Di Stefano, Carlo Mariani,
Antonella Romeo, Angelo Giuffrida, Roberta Adamo, Francesco Monaco, Wanda Deste,
Antonino S. Rubino
•T
ranscatheter aortic valve implantation (TAVI): assessment of myocardial systolic
performance with 2D speckle tracking echocardiography, Silvia Picarelli, Elisabetta Amici,
Carla Boschetti, Claudia Pandolfi, Rosario Fiorilli, Alberta Cifarelli, Roberto Francavilla,
Roberto Violini, Giancarlo Gambelli
•S
urgery of aortic root and ascending aorta through an upper ministernotomy: single centreexperience, Luigi Specchia, Salvatore Nicolardi, Federica Mangia, Mattia Scognamiglio,
Olivera Rasovic, Salvatore Foggetti, Salvatore Lentini, Marcello Melone, Cristina Conti,
Rebani Sinani, Renato Gregorini, Giuseppe Di Eusanio
•C
ontractile properties of the right atrial myofilaments in patients with myxomatous mitral
valve degeneration, Constanze Bening, Uwe Mehlhorn, Ahmad Abugameh, Daniela Link,
Christian-Friedrich Vahl
•B
ologna early-experience with the Trifecta pericardial aortic valve prosthesis,
Luca Di Marco, S. Castrovinci, J. Alfonsi, G. Murana, A. Leone, D. Pacini, A. Loforte,
R. Di Bartolomeo
•S
upine exercise echocardiography irrelevant to assess exercise capacity,
Olivia Domanski, Augustin Coisne, Marjorie Richardson, Anne-Sophie Polge,
Anju Duva Pentiah, Stéphanie Mouton, Aida Ben Abda, David Montaigne
•H
emodynamic and regurgitation after TAVI. An in vitro study, Salaun Erwan,
Zenses Anne Sophie, Evin Morgane, Collart Frederic, Pibarot Philippe, Habib Gilbert,
Rieu Regis
•C
linical and echocardiographic outcomes at rest and under exercise after mitral valve
annuloplasty for ischemic mitral regurgitation: impact of different rings, Francesco Guccione,
Pietro Dioguardi, Egle Corrado, Patrizia Carità, Sebastiano Castrovinci, Giacomo Murana,
Emerico Ballo, Giuseppe Bianco, Khalil Fattouch
•P
ercutaneous mitral dilation; the alternative treatment to surgery, Farah Korchi,
Ilham Bensahi, Amina Elfhal, Rachida Habbal
•G
ender differences in patients with severe aortic stenosis: are women more “rigid”?
M. Baroni, E. Cerone, E. Milano, M. Solinas, S. Berti, AM. Mazzone
•A
logistic risk model predicts significant coronary artery disease in patients with
degenerative aortic valve disease, Mazzone Annamaria, Murzi Michele, Baroni Monica,
Miceli Antonio, Glauber Mattia, Solinas Marco, Berti Sergio, De Caterina Raffaele,
Gilmanov Dyniar
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
......................................................................
Discover more at
www.Daiichi-Sankyo.EU
......................................................................
Today, through a growing presence in emerging markets we are pleased to meet the
needs of patients in more than 50 countries around the world.
......................................................................
Building on our experience of innovation in the areas of cardiovascular diseases
and bacterial infections, Daiichi Sankyo is expanding into other important
therapeutic areas where significant unmet medical needs remain, such as the
development of medicines for blood clot and stroke prevention, cancer treatments,
and medicines for diabetes and related conditions.
......................................................................
Daiichi Sankyo is a global pharmaceutical company with a legacy of over 100 years
of scientific expertise and its corporate origin in Japan.
Notes
Information
ina
Barberini
lle
Qu
Vi
Tr
at
af
tro
o
ia
G
en
ov
a
os
tin
o
De
pr
et
is
ti
Na
zi
on
e
al
Ag
Pa
er
en
a
ac
a
Vi
a
Vi
a
a
G
rm
a
M
ila
ta
no
P il o t
Antico Palazzo
Rospigliosi****
Vi
d e ll a
ag gi o
Vi a XX IV M
V ia
Project Manager
Stéphanie Meyer
+ 33 646 10 48 26
Managing director
Vérane Bergeron Moreau + 33 621 78 87 16
Registration / Accommodation
Michèle Caboste
+ 33 613 96 08 70
Roma Eventi
Fontana Di Trevi
Vi
EVENT COORDINATORS’CONTACTS
Pi
Vi
V
ia
Termini
iob
1
a
Eurostars International
Palace Hotel****
a
z
V
o
rto
Vi
Q
e
rin
be
07.30 - 19.00
08.00 - 17.00
l
de
n
an
To
Um
Fontana di Trevi
ri
ui
e
al
nt
Republica
Via
or
REGISTRATION DESK OPENING HOURS
Friday October 24
Saturday October 25
Fo
a
Se
ur
de
XX
vo
a
e
Ca
ne
Vi
ll a
br
ta
ase
V ia R
m
tte
ae
e
le C a s
G
V ia
T r it o
del
st
a
Piazza Della Pilotta, 4 – 00187 Rome • Tel. +39 0667015176-77 • Fax: +39 0667015178
Nearby points of interest: Fontana di Trevi:150 m • Piazza Venezia: 400 m • Piazza di Spagna:
800 m • Quirinale: 300 m
Capo
V ia d i
Si
Vi
Roma Eventi Fontana Di Trevi, Rome, ITALY
a
a
Vi
Vi
Congress venue:
V ia
Pan
na
is p e r
Vi
a
P
l
ao
in
a
Vi
a
Na
po
leo
ne
III
HOTEL LIST
Stay alert
Antico Palazzo Rospigliosi****
Eurostars International Palace Hotel****
Via Liberiana, 21 - 00185 Rome, Italy
10 min walking distance from Roma Eventi
Fontana di Trevi
Via Nazionale, 46 - 00184 Rome, Italy
10 min walking distance from Roma Eventi
Fontana di Trevi
Access: at a walking distance from the Termini
Railway Station of Rome (150 meters). From
Termini follow Via Cavour-Piazza Dell’Esquilino.
Access: at a walking distance from the Termini
Railway Station of Rome (150 meters). From
Termini follow Via Cavour-Piazza Dell’Esquilino.
Keep up to date with the highest quality material,
both scientific and clinical, from all areas of
cardiovascular imaging with email table of
contents alerts from the European Heart
Journal – Cardiovascular Imaging
At the heart of Cardiology
Sign up under the ‘Alerting Services’ heading at:
ehjcimaging.oxfordjournals.org
www.eurovalvecongress.com
cardiac surgery solutions
patients live innovation.
Fontana
Exhibition hall
+0.64
+0.48
+0.64
+0.32
+0.48
+0.16
0.00
Plenary room
-0.16
+0.48
-0.32
+0.32
+0.16
0.00
-0.16
-0.32
Buffet
Buffet
+1.41
0.00
-0.48
-0.32
-0.16
0.00
+0.16
+0.16
+0.32
-0.32
+0.48
B
-0.16
+0.64
2
1
0.00
+0.16
+0.32
B
Office
Preview
0.00
+0.48
+0.64
3
4
+0.64
Exhibition hall
Posters
7
Booth Company
1
2
3
4
5
6
7
Sorin group
Esaote
ENTRANCE
1,89
Buffet
5
Buffet
6
Registration
desk
2,04
Cloakroom
EXHIBITION TIMES
Friday October 24
Saturday October 25
08.00 - 19.00
08.00 - 14.00
Philips
Hitachi
EACVI
Micardia
GE Healthcare
equipped to perform
perceval
memo 3d
divine [id] agency
• Stéphanie Meyer: smeyer@divine-id.com
Mob. +33 (0) 646 10 48 26
•V
érane Bergeron Moreau: vbergeron@divine-id.com
• 17, rue Venture - 13001 Marseille, France
• Tel. +33 (0) 491 57 19 60
• Fax +33 (0) 491 57 19 61
• www.divine-id.com
IM-00280 A
ORGANIZATION
Heartlink
© 2014 Sorin Group
www.sorin.com
info.cardiacsurgery@sorin.com
ETHICAL
COLLABORATION
IN HEALTHCARE
CERTIFIED
Licensed by Eucomed
TM
www.eurovalvecongress.com
ACKNOWLEDGEMENTS 2014